TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells

Cytokine

Volumn 9, Issue 10, 1997, Pages 770-780

  Smith, Mark R ^a   Kung, Hsiang Fu ^b   Durum, Scott K ^c   Colburn, Nancy H ^d   Sun, Yi ^e  

^a SAIC FREDERICK INC   (United States)

^b Laboratory of Biochemical Physiology   (United States)

^c Lab of Molecular Immunoregulation   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e PFIZER INC   (United States)

Author keywords

Apoptosis; Cell death; Matrix metalloproteinases; Tissue inhibitor of metalloproteinases; TNF ; TNF receptors

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CULTURE; CELL CYCLE G1 PHASE; CELL DEATH; CELL LYSATE; CELL SURFACE; COLON CARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 0031259566     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0233     Document Type: Article

References (34)

1. 1. Alexander CM, Werb Z (1991) Extracellular matrix degradation. In Hay ED (editor) 2nd Edn. Cell Biology of Extracellular Matrix, Plenum Press, New York, 255-302.
2. 2. Liotta LA, Stetler-Stevenson WG (1990) Metalloproteinases and cancer invasion. Semin Cancer Biol 1:99-106.
3. 3. Pelletier JP, Mineau F, Faure MP, Martel-Pelletier J (1990) Imbalance between the mechanisms of activation and inhibition of metalloproteinases in the early lesions of experimental osteoarthritis. Arth Rheum 33:1466-1476.
4. 4. Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455-463.
5. 5. Williamson RA, Marston FA, Angal S, Koklitis P, Panico M, Morris HR, Carne AF, Smith BJ, Harris TJ, Freedman RB (1990) Disulfide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 268:267-274.
6. 6. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1992) Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250.
7. 7. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in cells and tissues. J Biol Chem 269:9352-9360.
8. 8. Sun Y, Hegamyer G, Colburn NH (1994) Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: One is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res 54:1139-1144.
9. 9. Apte SS, Olson B, Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270:14313-14318.
10. 10. Wick M, Burger C, Brusselbach S, Lucibello F, Muller R (1994) A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 269:18953-18960.
11. 11. Uria JA, Ferrando AA, Velasco G, Freije JMP, Lopez-Otin C (1994) Structure and expression in breast tumors of human TIMP-3. A new member of the metalloproteinase inhibitor family. Cancer Res 54:2091-2094.
12. 12. Silbiger SM, Jacobsen VL, Cupples RL, Koski RA (1994) Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141: 293-297.
13. 13. Weber BHF, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nature Genet 8:352-356.
14. 14. Jones SE, Jomary C, Neal MJ (1994) Expression of TIMP-3 mRNA is elevated in retinas affected by simplex retinitis pigmentosa. FEBS Lett 352:171-174.
15. 15. Sun Y, Hegamyer G, Kim H, Sithanandam K, Li H, Watts R, Colburn NH (1995) Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 (mTIMP-3) and its promoter: Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation. J Biol Chem 270:19312-19319.
16. 16. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung H-F, Colburn NH, Sun Y (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17:1805-1811.
17. 17. Smith MR, Munger WE, Kung H-f, Takacs L, Durum SK (1990) Direct evidence for an intracellular role for tumor necrosis factor-α: Microinjection of tumor necrosis factor kills target cells. J Immunol 144:162-169.
18. 18. Schmid DS, Hornung R, McGarth KM, Paul N, Ruddle NH (1987) Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. Lymphokine Res 6:195-202.
19. 19. Rubin BY, Smith LJ, Hellermann GR, Lunn RM, Richardson NK, Anderson SL (1988) Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res 48:6006-6010.
20. 20. Laster SM, Wood JG, Gooding LR (1988) Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141:2629-2634.
21. 21. Singh N, Sun Y, Nakamura K, Smith MR, Colburn NH (1995) C-jun/AP-1 as possible mediators of tumor necrosis factor-α induced apoptotic response in mouse JB6 tumor cells. Oncol Res 7:353-362.
22. 22. McGeehan GM, Becherer JD, Bast RC, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S (1994) Regulation of tumor necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370:558-561.
23. 23. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL (1994) Processing of tumor necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557.
24. 24. Gullberg U, Lantz M, Lindvall L, Olsson I, Himmler A (1992) Involvement of an Asn/Val cleavage site in the production of a soluble form of a human tumor necrosis factor (TNF) receptor. Site-directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain. Eur J Cell Biol 58:307-312.
25. 25. Engelmann H, Novick D, Wallach D (1990) Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 265:1531-1536.
26. 26. Baker SJ, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9.
27. 27. Kriegler M, Ferez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53.
28. 28. Nophar Y, Kemper O, Brakebusch C, Englemann H, Zwang R, Aderka D, Holtmann H, Wallach D (1990) Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type ITNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9:3269-3278.
29. 29. Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM (1990) Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci USA 87:6151-6155.
30. 30. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 89:4845-4849.
31. 31. Ware CF, Crowe PD, VanArsdale TL, Andrews JL, Grayson MH, Jerzy R, Smith CA, Goodwin RG (1991) Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector cells. J Immunol 147:4229-4238.
32. 32. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarns K (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370:218-220.
33. 33. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF (1995) A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 181:1205-1210.
34. 34. Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM (1995) A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 155:5198-5205.